[go: up one dir, main page]

DK3334444T3 - Sammensætning af mælkesyrebakterier til anvendelse i behandling af infektioner, der skyldes propionibacterium acnes, og navnlig til acne - Google Patents

Sammensætning af mælkesyrebakterier til anvendelse i behandling af infektioner, der skyldes propionibacterium acnes, og navnlig til acne Download PDF

Info

Publication number
DK3334444T3
DK3334444T3 DK16767362.3T DK16767362T DK3334444T3 DK 3334444 T3 DK3334444 T3 DK 3334444T3 DK 16767362 T DK16767362 T DK 16767362T DK 3334444 T3 DK3334444 T3 DK 3334444T3
Authority
DK
Denmark
Prior art keywords
acne
treatment
composition
lactic acid
acid bacteria
Prior art date
Application number
DK16767362.3T
Other languages
English (en)
Inventor
Giovanni Mogna
Original Assignee
Probiotical Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probiotical Spa filed Critical Probiotical Spa
Application granted granted Critical
Publication of DK3334444T3 publication Critical patent/DK3334444T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cosmetics (AREA)
DK16767362.3T 2015-08-13 2016-08-12 Sammensætning af mælkesyrebakterier til anvendelse i behandling af infektioner, der skyldes propionibacterium acnes, og navnlig til acne DK3334444T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITUB2015A003106A ITUB20153106A1 (it) 2015-08-13 2015-08-13 Composizione di batteri lattici per uso nel trattamento delle infezioni causate da Propionibacterium acnes e in particolare per l'acne
PCT/IB2016/054869 WO2017025936A2 (en) 2015-08-13 2016-08-12 Composition of lactic bacteria for use in the treatment of infections due to propionibacterium acnes and in particular for acne

Publications (1)

Publication Number Publication Date
DK3334444T3 true DK3334444T3 (da) 2022-03-14

Family

ID=54884143

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16767362.3T DK3334444T3 (da) 2015-08-13 2016-08-12 Sammensætning af mælkesyrebakterier til anvendelse i behandling af infektioner, der skyldes propionibacterium acnes, og navnlig til acne

Country Status (13)

Country Link
US (2) US11628193B2 (da)
EP (1) EP3334444B1 (da)
JP (3) JP2018522919A (da)
KR (1) KR102692232B1 (da)
CN (1) CN108697743B (da)
BR (1) BR112018001811A2 (da)
CA (1) CA2993506A1 (da)
DK (1) DK3334444T3 (da)
ES (1) ES2907991T3 (da)
HK (1) HK1254897A1 (da)
IT (1) ITUB20153106A1 (da)
RU (1) RU2728161C2 (da)
WO (1) WO2017025936A2 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018051895A1 (ja) 2016-09-15 2018-03-22 キリン株式会社 乳酸菌を有効成分として含む、皮膚における特定細菌の異常増殖に起因する皮膚の状態の悪化を防止又は改善するための組成物
IT201700068009A1 (it) * 2017-06-19 2018-12-19 Probiotical Spa Composizione comprendente ceppi di batteri appartenenti alla specie Lactobacillus salivarius per il trattamento del morbo di Parkinson
IT201700068000A1 (it) * 2017-06-19 2018-12-19 Probiotical Spa Composizione di batteri e/o loro derivati la cui attività biologica è stata specificatamente studiata per il miglioramento dello stato di salute differenziato per maschi e femmine
KR101925135B1 (ko) * 2018-08-23 2018-12-04 주식회사 지놈앤컴퍼니 신규의 큐티박테리움 아비덤 균주, 및 이러한 균주 또는 이의 배양물을 포함하는 아토피 피부염 예방 또는 치료용 조성물
US20220000944A1 (en) * 2018-11-09 2022-01-06 The Ritsumeikan Trust Agent for controlling sebaceous glands
AU2020279533A1 (en) * 2019-05-20 2021-12-23 L'ORéAL S.A. Composition for treatment, alleviation or prophylaxis of acne
CN114901242A (zh) * 2019-10-03 2022-08-12 S-生物医药有限公司 新的皮肤护理组合物
BR112022006367A2 (pt) * 2019-10-03 2022-06-28 S Biomedic Composição inovadora para cuidados com a pele
WO2021063526A1 (en) * 2019-10-03 2021-04-08 S-Biomedic Novel skin care composition
US20220265545A1 (en) * 2020-02-13 2022-08-25 Cj Cheiljedang Corporation Composition for improving skin condition
IT202000018901A1 (it) * 2020-07-31 2022-01-31 Synbalance Srl Composizioni probiotiche e loro uso nella prevenzione e/o nel trattamento di patologie e/o disturbi della pelle
CN114032190B (zh) * 2021-08-20 2023-04-28 江南大学 一株可发酵石斛且其发酵液可有效修复日光皮炎的罗伊氏乳杆菌
CN114558109B (zh) * 2022-03-23 2024-05-28 武汉珈诗丽科技有限公司 阿胶糖肽在制备调节皮肤微生态制剂中的应用
CN115181696B (zh) * 2022-06-27 2023-08-29 广东粤港澳大湾区国家纳米科技创新研究院 一种长双歧杆菌cb39Y4及其应用
CN115181699B (zh) * 2022-06-28 2023-08-29 广东粤港澳大湾区国家纳米科技创新研究院 一株长双歧杆菌cb20y1及其应用
CN118773047B (zh) * 2024-06-14 2025-01-28 中南大学湘雅医院 一种益生菌组合及其干预玫瑰痤疮的产品
CN119498405A (zh) * 2025-01-22 2025-02-25 四川厌氧生物科技有限责任公司 多功能发酵剂菌株及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2265521C (en) * 1996-09-13 2009-06-09 Clemson University Anti-bacterial composition for treating acne
ITMI20042189A1 (it) * 2004-11-16 2005-02-16 Anidral Srl Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale
EP1736537A1 (en) 2005-06-22 2006-12-27 OrganoBalance GmbH Methods and means for protecting the skin against pathogenic microorganisms
ITMI20072260A1 (it) * 2007-12-03 2009-06-04 Anidral Srl Una composizione a base di batteri probiotici in associazione con un prebiotico e suo uso nella prevenzione e/o nel trattamento di patologie e/o infezioni respiratorie e nel miglioramento della funzionalita intestinale.
FR2938437B1 (fr) * 2008-11-19 2020-03-27 Société des Produits Nestlé S.A. Utilisation cosmetique de microorganisme pour le traitement des peaux grasses
AR077822A1 (es) * 2009-08-11 2011-09-28 Sanofi Aventis Us Llc Proceso para preparar 2-cloro-3n-(2-benzimidazolil)-4-metil-3-tienilamina util como un inhibidor del intercambiador de sodio/protones de tipo 3
IT1398730B1 (it) 2009-09-08 2013-03-18 Giuliani Spa Ceppo batterico probiotico e suoi usi per via orale e topica
IT1403661B1 (it) * 2011-01-28 2013-10-31 Probiotical Spa Composizione effervescente in forma solida per uso in applicazioni vaginali per il trattamento di infezioni vaginali.
ITMI20120131A1 (it) * 2012-02-01 2013-08-02 Probiotical Spa Batteri probiotici microincapsulati multistrato, loro produzione ed uso
KR101430084B1 (ko) * 2012-03-23 2014-08-14 조선대학교산학협력단 프로피오니박테리움 아크네스에 작용하는 신규한 항생 펩타이드 및 이의 용도
FR2999601B1 (fr) * 2012-12-17 2015-01-30 Urgo Lab Methode pour prevenir et/ou traiter les infections, colonisations ou maladies liees a staphylococcus aureus, pseudomonas aeruginosa, streptococcus pyogenes, enterococcus faecium, enterobacter cloacae, proteus mirabilis et/ou bacteroides fragilis
KR20150087634A (ko) * 2014-01-22 2015-07-30 주식회사한국야쿠르트 여드름 원인균 프로피오니박테리움 아크네스의 생장억제 효능을 가지는 락토바실러스 파라카제이 hy7301 및 이를 유효성분으로 함유하는 제품

Also Published As

Publication number Publication date
RU2018106510A (ru) 2019-09-16
US20190015463A1 (en) 2019-01-17
KR20180044313A (ko) 2018-05-02
EP3334444B1 (en) 2021-12-08
US11628193B2 (en) 2023-04-18
CN108697743B (zh) 2022-02-15
JP2023061935A (ja) 2023-05-02
JP7610630B2 (ja) 2025-01-08
ITUB20153106A1 (it) 2017-02-13
WO2017025936A2 (en) 2017-02-16
JP2022002509A (ja) 2022-01-11
HK1254897A1 (zh) 2019-08-02
BR112018001811A2 (pt) 2018-09-18
WO2017025936A3 (en) 2017-03-23
ES2907991T3 (es) 2022-04-27
CN108697743A (zh) 2018-10-23
CA2993506A1 (en) 2017-02-16
EP3334444A2 (en) 2018-06-20
JP2018522919A (ja) 2018-08-16
US20230226128A1 (en) 2023-07-20
RU2728161C2 (ru) 2020-07-28
RU2018106510A3 (da) 2020-01-27
KR102692232B1 (ko) 2024-08-05

Similar Documents

Publication Publication Date Title
DK3334444T3 (da) Sammensætning af mælkesyrebakterier til anvendelse i behandling af infektioner, der skyldes propionibacterium acnes, og navnlig til acne
IL257978B (en) Use of pasteurized akkermansia for treating metabolic disorders
HK1247835A1 (zh) 甲狀旁腺功能減退症的治療
MA46092A (fr) Inhibiteurs de processus métaboliques cellulaires
DK2996701T3 (da) Sammensætning omfattende mælkesyrebakterier til anvendelse i den forebyggende og/eller helbredende behandling af bakteriel vaginose
BR112018001522A2 (pt) micróbios agricolamente benéficos, composições microbianas e consórcios
BR112017017003A2 (pt) micróbios agricolamente benéficos, composições microbianas e consórcios
IL249061B (en) Combination, composition, and method of administering the combination or composition to animals
DK3229840T3 (da) 3,5-dihydroxy-4-isopropyl-trans-stilben til anvendelse i topisk behandling af akne
DK3204386T3 (da) Substituerede aminopurinforbindelser, sammensætninger deraf og fremgangsmåder til behandling dermed
DK3242957T3 (da) Bakterieholdige sammensætninger og fremgangsmåder til anvendelse af samme til behandling og/eller forebyggelse af gastrointestinale, metaboliske og/eller andre sygdomme
DK3524255T3 (da) Sammensætning til behandling af acne
DK3102200T3 (da) Terapeutisk forbindelse og sammensætning
HK1256909A1 (zh) Glp-1和其在用於治療代謝疾病的組合物中的用途
EP3177311C0 (en) COMBINATION OF MEDICINAL PRODUCTS CONTAINING CABOZANTINIB AND A PROTEASOME INHIBITOR FOR THE TREATMENT OF MULTIPLE MYELOMA
DK3212776T3 (da) Sammensætninger og fremgangsmåder i forbindelse med beta-glucosidase
HK1255251A1 (zh) 用於治療痤瘡的氨氧化細菌
DK3390325T3 (da) Gødning omfattende bakterier og protozoer
DK3185696T3 (da) Forbedrede sammensætninger af hetero- og homofermentative mælkesyrebakteriearter til ensilagekonservering med dobbelt formål
DK3133153T3 (da) Nye bakteriophager og sammensætning dermed
EP3612200A4 (en) COMPOSITIONS CONTAINING BACTERIOPHAGES OF PROPIONIBACTERIUM ACNES INTENDED FOR THE TREATMENT OF ACNE
DK3133151T3 (da) Nye bakteriophager og sammensætning dermed
DK3388085T3 (da) Farmaceutisk sammensætning og anvendelser deraf
DK3240821T3 (da) Lavdosis gashydrathæmmersammensætning og tilhørende fremgangsmåde
DK3432900T3 (da) Mælkesyrebakteriesammensæting til behandling af bakterielle vaginale infektioner forårsaget af gardnerella vaginalis og, hvis de forefindes, samtidige svampeinfektioner